Laurus Labs has informed that the Board of Directors of the Company at their meeting held on January 23, 2026 have resolved as follows: (1) Approval of Unaudited Financial Results for the quarter and nine-months ended December 31, 2025: Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended December 31, 2025 at their meeting held today i.e., January 23, 2026, which are enclosed along with Limited Review Reports issued by Deloitte Haskins & Sells LLP, the Statutory Auditors of the Company. The financial results are also available on the website of the Company at www.lauruslabs.com and also on the websites of BSE and National Stock Exchange of India viz. www.bseindia.com and www.nseindia.com respectively. (2) Noting of change in address of Corporate Office of the Company: The Board of Directors took note of the change in address of Corporate Office of the Company. The new corporate office address is as follows: Plot No. 103, Road No. 1, Jubilee Hills, Hyderabad- 500033, Telangana, India. The Board Meeting commenced at 02.00 pm and concluded at 02.40 pm.

The above information is a part of company’s filings submitted to BSE.